Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Schering-Plough AESCA Pharma GmbH |
---|---|
Information provided by: | Schering-Plough |
ClinicalTrials.gov Identifier: | NCT00279565 |
This randomized, single-center, controlled study is designed to evaluate the safety, tolerability, and efficacy of treatment with Peg-Intron with Rebetol in methadone or buprenorphine maintenance patients with hepatitis C.
Condition | Intervention | Phase |
---|---|---|
Hepatitis C, Chronic |
Drug: buprenorphine Drug: methadone Drug: pegylated interferon alfa-2b plus ribavirin |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Randomized, Controlled Study of Buprenorphine and Methadone in Hepatitis C Patients in Need of Treatment |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Lab parameters:
Exclusion Criteria:
Study ID Numbers: | P04279 |
Study First Received: | January 17, 2006 |
Last Updated: | February 28, 2007 |
ClinicalTrials.gov Identifier: | NCT00279565 |
Health Authority: | Austria: Federal Ministry for Health and Women |
buprenorphine methadone Peg-Intron Rebetol |
Interferon-alpha Liver Diseases Hepatitis, Chronic Interferons Ribavirin Hepatitis, Viral, Human Naphazoline Hepatitis Virus Diseases Oxymetazoline Methadone |
Buprenorphine Digestive System Diseases Guaifenesin Phenylephrine Peginterferon alfa-2b Phenylpropanolamine Hepatitis C Interferon Alfa-2a Hepatitis C, Chronic Interferon Alfa-2b |
Respiratory System Agents Anti-Infective Agents RNA Virus Infections Flaviviridae Infections Immunologic Factors Antineoplastic Agents Growth Substances Narcotic Antagonists Physiological Effects of Drugs Central Nervous System Depressants Narcotics Angiogenesis Inhibitors |
Antiviral Agents Pharmacologic Actions Sensory System Agents Therapeutic Uses Growth Inhibitors Angiogenesis Modulating Agents Analgesics Peripheral Nervous System Agents Antitussive Agents Central Nervous System Agents Analgesics, Opioid |